×
0 0.00012199585214109 -0.000121995852140916 -0.000121995852140916 -0.000121995852140916 0.000731975112846191 0.000731975112846191 0.000853970964987281
Stockreport

FDA OKs Novartis' radiotherapy Lutathera for certain neuroendocrine tumors [Seeking Alpha]

ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE (AAAP)  More Company Research Source: Seeking Alpha
Last advanced accelerator applications sa american de earnings: 8/31 07:00 am Check Earnings Report
PDF FDA OKs Novartis' radiotherapy Lutathera for certain neuroendocrine tumorsThe FDAapproves Novartis (NVS+0.1%) unit Advanced Accelerator Applications S.A.'s LUTATHERA (lutetium Lu 177) for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adult patients, an Orphan Drug indication.LUTATHERA, a targeted therapy that carries a radioactive component, is the first drug of its kind approved in the U.S.Novartiscompleted its $3.9B acquisition of Advanced Accelerator on January 22.Previously:Novartis scoops up Advanced Accelerator (Oct. 30, 2017)Click to subscribe to real-time analytics on NVSNow read:Novartis: Future Looks Bright, But Valuation Is Full » [Read more]

IMPACT SNAPSHOT EVENT TIME: AAAP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS